Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Quipt Home Medical (QIPT) EBIT (2020 - 2025)

Historic EBIT for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to $1.0 million.

  • Quipt Home Medical's EBIT rose 12857.14% to $1.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.2 million, marking a year-over-year decrease of 76359.92%. This contributed to the annual value of -$3.8 million for FY2025, which is 44287.0% down from last year.
  • Per Quipt Home Medical's latest filing, its EBIT stood at $1.0 million for Q4 2025, which was up 12857.14% from -$1.4 million recorded in Q3 2025.
  • Quipt Home Medical's 5-year EBIT high stood at $4.4 million for Q1 2022, and its period low was -$1.8 million during Q2 2025.
  • Moreover, its 5-year median value for EBIT was $533500.0 (2022), whereas its average is $450900.0.
  • Per our database at Business Quant, Quipt Home Medical's EBIT soared by 21644.07% in 2022 and then plummeted by 9590000.0% in 2024.
  • Quarter analysis of 5 years shows Quipt Home Medical's EBIT stood at -$1.2 million in 2021, then skyrocketed by 216.44% to $1.4 million in 2022, then dropped by 21.76% to $1.1 million in 2023, then tumbled by 58.33% to $448000.0 in 2024, then surged by 128.57% to $1.0 million in 2025.
  • Its EBIT was $1.0 million in Q4 2025, compared to -$1.4 million in Q3 2025 and -$1.8 million in Q2 2025.